Investing in biotech

The word “biotech” can easily deter investors. It conjures memories of half-understood science classes, endless clinical trials, and indecipherable formulae. But this clouds the reality that this is a market sector in many ways much like any other, a theme we explore throughout our new sector report on biotech. This year the sector is well-placed…